Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F66K7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,464
Award facts
- Contract value 100% obligated
- $11,463.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,463.52 firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 22, 2026, for the supply of Dupixent 300 mg/2 mL syringes. The contract, which is set to be completed by January 23, 2026, represents a single delivery order issued under a larger Indefinite Delivery Contract vehicle. This delivery order falls under the DLA Troop Support Medical's comprehensive pharmaceutical supply framework, which supports military healthcare systems globally. No set-aside designation was applied to this award, indicating it was competitively awarded on a full and open basis.
This delivery order is executed through Amerisourcebergen Drug Corp's parent company, Cencora, Inc., which maintains a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical running through December 2031. The contract vehicle enables the delivery of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military treatment facilities and veterans' healthcare programs. Dupixent, a specialty biologic medication used primarily for atopic dermatitis, asthma, and eosinophilic conditions, represents the type of specialized pharmaceutical commodity routinely supplied by Amerisourcebergen through its federal contracts to serve Department of Defense and other military healthcare organizations.
Quick answers
Who was awarded contract SPE2DR26F66K7?
SPE2DR26F66K7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F66K7 worth?
The government has obligated $11,464 on SPE2DR26F66K7.
Is contract SPE2DR26F66K7 an order under another contract?
Yes. SPE2DR26F66K7 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66K7 competed?
The extent of competition for SPE2DR26F66K7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award